GENEVA, SWITZERLAND / ACCESS Newswire / August 11, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to ...
GENEVA, SWITZERLAND / ACCESS Newswire / June 20, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief or the Company), a biopharmaceutical company committed to delivering ...
GENEVA and LAUSANNE (Oct. 8, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief or the Company), a biopharmaceutical company committed to delivering innovative treatment ...
(RTTNews) - Relief Therapeutics Holding SA (RLFTF, RLF.SW), a biopharmaceutical company, on Tuesday said it has published a joint presentation deck ahead of the expected mid-December 2025 closing of ...
Shareholders approve all EGM proposals related to the combination with NeuroX Business combination expected to close in December 2025 Relief to be renamed MindMaze Therapeutics Holding SA upon closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results